1. bookVolume 67 (2017): Edizione 3 (September 2017)
Dettagli della rivista
License
Formato
Rivista
eISSN
1846-9558
Prima pubblicazione
28 Feb 2007
Frequenza di pubblicazione
4 volte all'anno
Lingue
Inglese
Accesso libero

Development of a new HPLC method for wogonin in rat plasma: Compatibility of standard and test samples

Pubblicato online: 30 Aug 2017
Volume & Edizione: Volume 67 (2017) - Edizione 3 (September 2017)
Pagine: 373 - 384
Accettato: 24 May 2017
Dettagli della rivista
License
Formato
Rivista
eISSN
1846-9558
Prima pubblicazione
28 Feb 2007
Frequenza di pubblicazione
4 volte all'anno
Lingue
Inglese

1. H. Kataoka and H. L. Lord, Sampling and Sample Preparation for Clinical and Pharmaceutical Analysis, in Sample and Sample Preparation for Field and Laboratory (Ed. J. Pawliszyn), 1st ed., Elsevier, Amsterdam 2002.10.1016/S0166-526X(02)80060-5Search in Google Scholar

2. F. Xiaofang, L. Yiping and L. Huwei, Sample preparation for pharmaceutical analysis, 381 (2005) 75–77; DOI: 10.1007/s00216-004-2894-5.10.1007/s00216-004-2894-515599498Search in Google Scholar

3. R. F Venn, Physicochemical Properties of Drugs and Metabolites and their Impact on Bioanalysis, in Principles and Practice of Bioanalysis, 2nd ed., CRC Press, New York 2008.Search in Google Scholar

4. L. Ohannesian and A. Streeter, Handbook of Pharmaceutical Analysis, Taylor & Francis, New York 2001.10.1201/9780203908389Search in Google Scholar

5. N. El-Najjar, R. A. Ketola, T. Nissila, T. Mauriala, M. Antopolsky, J. Janis, H. Gali-Muhtasib, A. Urtti and H. Vuorela, Impact of protein binding on the analytical detectability and anticancer activity of thymoquinone, J. Chem. Biol.4 (2011) 97–107; DOI: 10.1007/s12154-010-0052-4.10.1007/s12154-010-0052-4312462722229047Search in Google Scholar

6. T. Li, N. Li, Q. Guo, H. Ji, D. Zhao, S. Xie, X. Li, Z. Qiu, D. Han, X. Chen and Q. You, Inhibitory effects of wogonin on catalytic activity of cytochrome P450 enzyme in human liver microsomes, Eur. J. Drug Metab. Pharmacokinet. 36 (2011) 249–256; DOI: 10.1007/s13318-011-0050-0.10.1007/s13318-011-0050-021713461Search in Google Scholar

7. L. Jian-chun, C. Fei-hu, D. Hai-jun and G. Shu, Study on plasma concentration and bioavailability of wogonin in beagle dogs, Chin. Herbal Med.3 (2011) 144–149; DOI: 10.3969/j.issn.1674-6384.2011.02.010.Search in Google Scholar

8. Y. H. Kim, D. W. Jeong, I. B. Paek, H. Y. Ji, Y. C. Kim, D. H. Sohn and H. S. Lee, Liquid chromatography with tandem mass spectrometry for the simultaneous determination of baicalein, baicalin, oroxylin A and wogonin in rat plasma, J. Chromatogr. B844 (2006) 261–267; DOI: 10.1016/j.jchromb.2006.07.021.10.1016/j.jchromb.2006.07.02116893689Search in Google Scholar

9. Y. H. Kim, D. W. Jeong, Y. C. Kim, D. H. Sohn, E. S. Park and H. S. Lee, Pharmacokinetics of baicalein, baicalin and wogonin after oral administration of a standardized extract of Scutellaria baicalensis, PF-2405 in rats, Arch. Pharm. Res. 30 (2007) 260–265.10.1007/BF0297770317366750Search in Google Scholar

10. C. Li, L. Zhang, G. Lin and Z. Zuo, Identification and quantification of baicalein, wogonin, oroxylin A and their major glucuronide conjugated metabolites in rat plasma after oral administration of Radix scutellariae product, J. Pharm. Biomed. Anal. 54 (2011) 750–758; DOI: 10.1016/j.jpba.2010.10.005.10.1016/j.jpba.2010.10.00521051171Search in Google Scholar

11. T. H. Tsai, C. J. Chou, T. R. Tsai and C. F. Chen, Determination of wogonin in rat plasma by liquid chromatography and its pharmacokinetic application, Planta Med. 62 (1996) 263–266; DOI: 10.1055/s-2006-957874.10.1055/s-2006-9578748693042Search in Google Scholar

12. FDA (CDER and CVM), Guidance for IndustryBioanalytical Method Validation, U.S. Department of Health and Human Services – Food and Drug Administration, Rockville (MD) May 2001.Search in Google Scholar

13. Z. E. Pápay, Z. Sebestyén, K. Ludányi, N. Kállai, E. Balogh, A. Kósa, S. Somavarapu, B. Böddi and I. Antal, Comparative evaluation of the effect of cyclodextrins and pH on aqueous solubility of apigenin, J. Pharm. Biomed. Anal. 117 (2016) 210–216; DOI: 10.1016/j.jpba.2015.08.019.10.1016/j.jpba.2015.08.01926363816Search in Google Scholar

14. J. Sun, F. Li, Y. Zhao, L. Zhao, C. Qiao, Z. Li, Q. Guo and N. Lu, LZ-207, a newly synthesized flavonoid, induces apoptosis and suppresses inflammation-related colon cancer by inhibiting the NF-κB signaling pathway, PLoS ONE10 (2015) e0127282; DOI: 10.1371/journal.pone.0127282.10.1371/journal.pone.0127282Search in Google Scholar

15. L. Tingting, K. Guo-jun, H. Hui-ling and Z. Lei, Determination of pKa values of wogonoside, wogonin and oroxylin-A by RP-HPLC, Chin. J. Pharm. Anal. 8 (2014) 1475–1480.Search in Google Scholar

16. A. Talbi, D. Zhao, Q. Liu, J. Li, A. Fan, W. Yang, X. Han and X. Chen, Pharmacokinetics, tissue distribution, excretion and plasma protein binding studies of wogonin in rats, Molecules19 (2014) 5538–5549; DOI: 10.3390/molecules19055538.10.3390/molecules19055538Search in Google Scholar

17. C. Xiaoyan, W. Hongyan, D. Yue and Z. Dafang, Quantitation of the flavonoid wogonin and its major metabolite wogonin-7β-d-glucuronide in rat plasma by liquid chromatography–tandem mass spectrometry, J. Chromatogr. B775 (2002) 169–178; DOI: 10.1016/S1570-0232(02)00288-X.10.1016/S1570-0232(02)00288-XSearch in Google Scholar

18. L. Wei, Comparison of the tissue distributions of flavonoids after oral administration of pure baicalin, Radix scutellariae and Scutellariae-Paeoniae couple extracts to rats, J. Med. Plants Res. 5 (2011) 6907–6915; DOI: 10.5897/jmpr11.410.10.5897/JMPR11.410Search in Google Scholar

19. L. Tong, M. Wan, L. Zhang, Y. Zhu, H. Sun and K. Bi, Simultaneous determination of baicalin, wogonoside, baicalein, wogonin, oroxylin A and chrysin of Radix scutellariae extract in rat plasma by liquid chromatography tandem mass spectrometry, J. Pharm. Biomed. Anal.70 (2012) 6–12; DOI: 10.1016/j.jpba.2012.03.051.10.1016/j.jpba.2012.03.051Search in Google Scholar

20. S. N. L. Grace and J. A. J. H. Critchley, The estimation of paracetamol and its major metabolites in both plasma and urine by a single high-performance liquid chromatography assay, J. Pharm. Biomed. Anal. 12 (1994) 1563–1572; DOI: 10.1016/0731-7085(94)00859-0.10.1016/0731-7085(94)00859-0Search in Google Scholar

21. S. Y. Fong, Y. C. Wong and Z. Zuo, Development of a SPE-LC/MS/MS method for simultaneous quantification of baicalein, wogonin, oroxylin A and their glucuronides baicalin, wogonoside and oroxyloside in rats and its application to brain uptake and plasma pharmacokinetic studies, J. Pharm. Biomed. Anal. 97 (2014) 9–23; DOI: 10.1016/j.jpba.2014.03.033.10.1016/j.jpba.2014.03.03324803030Search in Google Scholar

22. K. Maruyama, H. Nishigor and M. Iwatsuru, Location of drug binding sites on human serum albumin, Chem. Pharm. Bull. 34 (1986) 2989–2993.10.1248/cpb.34.29893769102Search in Google Scholar

23. Y. Liu, W. He, W. Gao, Z. Hu and X. Chen, Binding of wogonin to human gamma globulin, Int. J. Biol. Macromol. 37 (2005) 1–11; DOI: 10.1016/j.ijbiomac.2005.04.005.10.1016/j.ijbiomac.2005.04.00516242767Search in Google Scholar

24. J. Tian, J. Liu, J. Xie, X. Yao, Z. Hu and X. Chen, Binding of wogonin to human serum albumin: a common binding site of wogonin in subdomain IIA, J. Photochem. Photobiol. B74 (2004) 39–45; DOI: 10.1016/j.jphotobiol.2004.01.001.10.1016/j.jphotobiol.2004.01.00115043845Search in Google Scholar

25. J. Tian, J. Liu, Z. Hu and X. Chen, Interaction of wogonin with bovine serum albumin, Bioorg. Med. Chem. 13 (2005) 4124–4129; DOI: 10.1016/j.bmc.2005.02.065.10.1016/j.bmc.2005.02.06515911327Search in Google Scholar

Articoli consigliati da Trend MD

Pianifica la tua conferenza remota con Sciendo